Skip to main content

Table 2 Comparative analysis of patients with normal and prolonged QTc interval

From: Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study

Variables

QTc interval

p-value

Normal (N = 382) a

n (%)

Prolonged (N = 23) b

n (%)

Gender

 Male

229 (92.3)

19 (7.7)

0.03

 Female

153 (97.5)

4 (2.5)

Age (years)

  ≤ 20

75 (19.6)

6 (26.1)

0.45

 21–30

105 (27.5)

4 (17.4)

 31–40

94 (24.6)

4 (17.4)

  > 40

108 (28.3)

9 (39.1)

All prescribed drugs

 1

47 (12.3)

1 (4.3)

0.48

 2–3

240 (62.8)

15 (65.2)

  > 3

95 (24.9)

7 (30.4)

QT prolonging drugs

 1

216 (56.5)

10 (43.5)

0.22

  ≥ 2

166 (43.5)

13 (56.5)

QT drug-drug interactions

109 (28.5)

9 (39.9)

0.27

Diagnosis

 Psychosis

29 (7.6)

2 (8.7)

0.84

 Manic depressive psychosis

33 (8.6)

10 (13)

0.47

 Obsessive compulsive disorder

16 (4.2)

2 (8.7)

0.30

 Schizophrenia

16 (4.2)

1 (4.3)

0.97

 Major depression

200 (52.4)

11 (47.8)

0.67

 Hypomania

13 (3.4)

0 (0)

0.36

 Panic disorder

34 (8.9)

0 (0)

0.13

 Bipolar affective disorder

11 (2.9)

0 (0)

0.40

 Substance abuse

17 (4.9)

0 (0)

0.30

Co-morbid illnesses

 Hypertension

40 (10.5)

3 (13)

0.67

 Diabetes mellitus

17 (4.5)

0 (0)

0.80

 Epilepsy

13 (3.4)

0 (0)

0.27

QT prolonging drug classes (ATC Code)

 Antipsychotic (N05A)

140 (36.6)

11 (47.8)

0.28

 Proton pump inhibitors (A02BC)

48 (12.6)

1 (4.3)

0.24

 Antidepressant (N06A)

253 (66.2)

14 (60.9)

0.59

 Other drugs

19 (5)

2 (8.7)

0.43

  1. a Percentage calculated in total of 382 patients with normal QTc interval except gender; b Percentage calculated in total of 23 patients with prolonged QTc interval except gender